Legal Opinion

Demmler v. SmithKline Beecham Corp.

Superior Court of Pennsylvania

Decided February 14, 1996No. 192PublishedCited by 53 opinions

1Opinion of the Court

WIEAND, Judge:

On March 23, 1988, after taking a physician-prescribed dosage of the drug Parnate, Ada M. Demmler suffered a hypertensive crisis, which is a side effect of Parnate. The episode caused Demmler to become permanently disabled, including a partial paralysis and brain damage. Parnate is an antidepressant medication manufactured and sold by defendant, SmithKline Beecham Corporation (SmithKline), with warnings concerning hypertensive crises. It is a psychiatric drug classified as an monoamine oxidase inhibitor (MAOI). Christopher M. Erstling, M.D., a psychiatrist at Shadyside Hospital,…

2Cases cited21 opinions

  1. Hamil v. BashlineSupreme Court of Pennsylvania · 1978
  2. Incollingo v. EwingSupreme Court of Pennsylvania · 1971
  3. Incollingo v. EWINGSupreme Court of Pennsylvania · 1971
  4. Wyeth Laboratories v. ReyesSupreme Court of the United States · 1974
  5. Reyes v. Wyeth LaboratoriesCourt of Appeals for the Fifth Circuit · 1974

16 more not listed; retrieve them via the Exa API.

3Cited by53 opinions

  1. Lineberger v. WyethSuperior Court of Pennsylvania · 2006
  2. Krentz v. Consolidated Rail Corp.Supreme Court of Pennsylvania · 2006
  3. In Re Zyprexa Products Liability LitigationDistrict Court, E.D. New York · 2007
  4. Colacicco v. Apotex, Inc.District Court, E.D. Pennsylvania · 2006
  5. Coward v. Owens-Corning Fiberglas Corp.Superior Court of Pennsylvania · 1999

48 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API